Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 606
Recruiting: 317
Ph III recruiting: 30
Growth YoY: +37.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (571)

clinicaltrialsPublishedShowing 1,251–1,300 of 1,495 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00466687	Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma	completed	Phase 2	34	Vanderbilt-Ingram Cancer CenterOTHER	1	Jul 22, 2013	clinicaltrials
NCT00815607	Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma	completed	Phase 1	12	Alaunos TherapeuticsINDUSTRY	1	Jul 18, 2013	clinicaltrials